{"166661":{"#nid":"166661","#data":{"type":"event","title":"Petit Institute Seminar","body":[{"value":"\u003Cp\u003E\u003Cstrong\u003E\u0022siRNA-based Therapeutics: Challenges and Opportunities\u0022\u003C\/strong\u003E\u003Cbr \/\u003E\u003Cbr \/\u003E\u003Cstrong\u003EAnna Borodovsky, PhD\u003C\/strong\u003E\u003Cbr \/\u003E\u003Cstrong\u003EPrincipal Scientist\u003C\/strong\u003E\u003Cbr \/\u003E\u003Cstrong\u003EAlnylam Pharmaceuticals\u003C\/strong\u003E\u003Cbr \/\u003E\u003Cbr \/\u003EThe talk will be an overview of the history of siRNA drug development with a focus on the current state of the field. I will also discuss strategies used to deliver siRNAs for different disease applications. Most of the examples will be drawn from Alnylam\u2019s programs covering siRNA delivery to liver as well as extra-hepatic tissues. \u003Cbr \/\u003E\u003Cbr \/\u003EAnna Borodovsky is currently a Principal Scientist at Alnylam Pharmaceuticals where she as worked for the past 6 years focusing on various aspects of siRNA delivery. Prior to joining Alnylam she was a staff scientist at the Broad Institute Chemical Biology Program. Anna did her post-doctoral training at BiogenIdec, working on the role of TNF-family members in mouse models of inflammation. She received her PhD from Harvard University in 2002 working on deubiquitinating enzymes and has a BS in Chemistry from Emory University.\u003C\/p\u003E\u003Cp\u003EThe Parker H. Petit Institute hosts special guests and visitors throughout the year.\u0026nbsp; These seminars are open to all faculty and students.\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EPetit Institute Seminar - \u0022siRNA-based Therapeutics: Challenges and Opportunities\u0022 - Anna Borodovsky, PhD - Principal Scientist, Alnylam Pharmaceuticals\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"\u0022siRNA-based Therapeutics: Challenges and Opportunities\u0022 - Anna Borodovsky, PhD - Principal Scientist, Alnylam Pharmaceuticals"}],"uid":"27195","created_gmt":"2012-10-30 13:32:57","changed_gmt":"2016-10-08 02:00:59","author":"Colly Mitchell","boilerplate_text":"","field_publication":"","field_article_url":"","field_event_time":{"event_time_start":"2012-11-26T11:00:00-05:00","event_time_end":"2012-11-26T12:00:00-05:00","event_time_end_last":"2012-11-26T12:00:00-05:00","gmt_time_start":"2012-11-26 16:00:00","gmt_time_end":"2012-11-26 17:00:00","gmt_time_end_last":"2012-11-26 17:00:00","rrule":null,"timezone":"America\/New_York"},"extras":[],"related_links":[{"url":"http:\/\/www.ibb.gatech.edu\/","title":"Petit Institute for Bioengineering and Bioscience"},{"url":"http:\/\/www.alnylam.com\/","title":"Alnylam Pharmaceuticals"}],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[],"keywords":[{"id":"48431","name":"Alnylam Pharmaceuticals"},{"id":"48421","name":"Anna Borodovsky"},{"id":"248","name":"IBB"},{"id":"5168","name":"IBB Seminar"},{"id":"167724","name":"siRNA-based Therapeutics: Challenges and Opportunities"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[{"id":"1795","name":"Seminar\/Lecture\/Colloquium"}],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:mark.prausnitz@chbe.gatech.edu\u0022\u003EMark Prausnitz, PhD\u003C\/a\u003E\u003C\/p\u003E","format":"limited_html"}],"email":[],"slides":[],"orientation":[],"userdata":""}}}